• Aeternum Health acquired an option to buy 51% of American Renaissance Minerals, which is advancing the Nkamouna cobalt-nickel-manganese project in Cameroon.
• The option was acquired from Manaslu LLC for 50000000 common shares and 2000000 Series B preferred shares with 40 votes per share.
• American Renaissance Minerals is working with Cameroon’s government toward a new mining permit for Nkamouna following withdrawal of the prior permit in February 2025.
• Plans call for a mine-site concentrator to produce exportable cobalt-nickel-manganese concentrate, with Aeternum providing capital and engineering support.
• ARM licensed historical technical data from Geovic in January 2026 under terms that provide for Geovic to release claims over the project.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aeternum Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608070800PRIMZONEFULLFEED9805601) on August 07, 2026, and is solely responsible for the information contained therein.